Volume 26, Number 9—September 2020
Research
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France
Table 3
Laboratory findings | Non-ICU hospitalization, n = 90 |
ICU hospitalization, n = 10 |
p value | |||
---|---|---|---|---|---|---|
Median (IQR) | No. (%) | Median (IQR) | No. (%) | |||
Hemoglobin, g/dL | 11.4 (10.5–12.2) | 64 (66.7) | 9.8 (9.3–11.3) | 9 (90) | 0.02 | |
Platelet count, × 109/L | 230 (162–273) | 63 (70.0) | 205 (164–271) | 9 (90) | 0.98 | |
Leukocyte count, × 109 cells/L |
7.2 (5.4–8.9) |
63 (70.0) |
6.6 (6.1–7.2) |
9 (90) |
0.68 |
|
Lymphocyte count, × 109 cells/L | 1.15 (0.9–1.6) | 58 (64.4) | 0.77 (0.7–1) | 9 (90) | 0.01 | |
Lymphocytopenia, <1.00 × 109 cells/L |
NA |
21/58 (36.2)† |
NA |
8/9 (88.9)† |
0.008 |
|
Prothrombin time, % | 100 (99–100) | 53 (58.9) | 100 (100–100) | 7 (70) | 0.61 | |
aPPT, ratio | 1.06 (1–1.2) | 52 (57.8) | 1.12 (1–1.4) | 7 (70) | 0.16 | |
Prolonged aPPT ratio (>1.20) | NA | 13/53 (24.5)† | NA | 3/7 (43)† | 0.38 | |
Fibrinogen activity, g/L | 4.8 (4–5.8) | 45 (50.0) | 5.1 (4.5–5.5) | 6 (60) | 0.73 | |
AST, U/L | 25 (20–35) | 48 (53.3) | 30 (22–59) | 8 (80) | 0.38 | |
ALT, U/L | 17 (11–32) | 49 (54.4) | 19 (12–48) | 8 (80) | 0.46 | |
C-reactive protein, mg/L | 23 (9–42) | 53 (58.9) | 27 (22–108) | 8 (80) | 0.15 | |
Creatinine, μmol/L | 47 (41–57) | 45 (50.0) | 50 (38–55) | 7 (70) | 0.94 |
*ALT, alanine aminotransferase; aPPT, activated partial thromboplastin time; AST, aspartate aminotransferase; ICU, intensive care unit; IQR, interquartile range; NA, not applicable.
†Per available results.
Page created: July 02, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.